Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy
Khaled W. Kabbara, MD, and colleagues, research treatment options for cholangiocarcinoma.
Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer
Recent improvements in our understanding of the biology of colorectal cancer have led to the identification of several important prognostic and predictive markers of disease-associated risk and treatment response for the individual patient.
2 Clarke Drive Cranbury, NJ 08512